“A Randomised Single Blind Controlled Trial to Assess Effect of Amalaki (Emblica Officinalis) 30 CH of Type 2 Diabetes Mellitus Taking Conventional Treatment As Add on Therapy : A Pilot Study ”. Advancements in Homeopathic Research, vol. 4, no. 4, Aug. 2022, pp. 43-53, https://journals.acspublisher.com/index.php/ahr/article/view/2024.